Cell Based Assays Compound Screening Drugs 
The ChEMBL-og
APRIL 16, 2024
We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g. FDA. This data is currently available for European Medicines Agency drugs only.
The Pharma Data
JANUARY 6, 2021
Next-generation digital technologies are having an immense impact on the drug discovery process. The pharma industry is witnessing a steep rise in the use of AI-driven solutions in early-stage drug discovery, deep-learning technologies for compound screening, and lead identification and automation enhancements in the lab.
Expert insights. Personalized for you.
108 
Let's personalize your content